Published in Cancer Weekly, August 24th, 2004
"Moreover, the idenfication of susceptible genes other than TP will be desired for prediction or treatment of 5'-dFUR," noted K. Mimori and coauthors at Kyushu University. "We initially established conditions for the MTT assay system in vivo to compare the growth inhibition rate and TP activity in 18 cases of CRC."
"TP activity levels were...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.